Mechanisms regulating vascular and lymphatic regeneration in the heart after myocardial infarction

Bronwyn Berkeley1, Michelle Nga Huen Tang1, Mairi Brittan1

  • 1Centre for Cardiovascular Science, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.

PubMed

Insights

Cardiovascular regeneration research explores stimulating heart repair after myocardial infarction. Understanding neovascularisation and lymphangiogenesis is key for developing new heart failure therapies.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Pathology

Background:

  • Myocardial infarction (MI) causes irreversible heart injury, with survivors facing high heart failure risk.
  • Neonatal heart regeneration offers a model for exploring adult cardiac repair strategies.
  • Restoring vascular and lymphatic networks post-MI is crucial for myocardial regeneration.

Purpose of the Study:

  • To review research on cardiovascular regeneration, focusing on neovascularisation and lymphangiogenesis.
  • To explore endogenous mechanisms regulating vascular and lymphatic expansion after MI.
  • To discuss therapeutic strategies for promoting cardiac repair.

Main Methods:

  • Literature review of pre-clinical and clinical studies.
  • Analysis of endogenous mechanisms in cardiac development and disease.
  • Evaluation of therapeutic interventions for neovascularisation and lymphangiogenesis.

Main Results:

  • Early reperfusion improves MI survival but not long-term heart function.
  • Neovascularisation and lymphangiogenesis are essential for cardiac regeneration.
  • Understanding developmental pathways may inform adult regenerative therapies.

Conclusions:

  • Targeting neovascularisation and lymphangiogenesis holds therapeutic potential for heart failure post-MI.
  • Further research into endogenous repair mechanisms can guide future cardiovascular treatments.
  • Translating regenerative strategies requires a deeper understanding of vascular and lymphatic dynamics.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.6K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
713
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
2.4K